Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-ggqkh Total loading time: 0 Render date: 2025-04-28T16:49:45.308Z Has data issue: false hasContentIssue false

6 - Biochemistry of autism: changes in serotonin, reelin and oxytocin

Published online by Cambridge University Press:  04 February 2011

By
Elizabeta B. Mukaetova-Ladinska ,
Jodie Westwood  and
Elaine Perry
Edited by
Ilona Roth  and
Payam Rezaie
Ilona Roth
Affiliation:
The Open University, Milton Keynes
Payam Rezaie
Affiliation:
The Open University, Milton Keynes
Get access

Summary

Autism is a neurodevelopmental disorder characterised by impaired social skills, communication deficits and repetitive behaviours. Alterations in a number of neurotransmitter signalling systems and neuroregulatory proteins have been reported in individuals with autism spectrum disorders (ASD). The most compelling evidence seems to suggest an imbalance in excitatory and inhibitory impulses in the premature autistic brain, combined with defects in secondary neurotransmitter systems, resulting in autistic traits. Serotonin, known to be disrupted in ASD, facilitates the release of both reelin and oxytocin, with excessive levels of serotonin resulting in a decrease in reelin and oxytocin. Deficits in developmental growth factors, such as reelin, may regulate or be regulated by oxytocin, thus contributing to both neurodevelopmental arrest and altered social behaviour, characteristic for the autistic spectrum. In this review we therefore concentrate on the role of the serotonin neurotransmitter and the two neuroregulatory proteins (reelin and oxytocin), and evaluate the pharmacological interventions available at the moment, associated with the latter neurochemical changes in autism.

Introduction

Autism is regarded as a heterogeneous neurodevelopmental disorder, characterised by a spectrum of impaired social skills, communication deficits, repetitive behaviour and frequently associated with co-morbid disorders (e.g. obsessive compulsive disorder, epilepsy, Tourette syndrome, attention deficit hyperactivity disorder, tuberous sclerosis and Fragile X syndrome, among others; Gillberg and Billstedt, 2000). A significant number of individuals with autism also show hyperactivity, anxiety and self-injurious behaviours.

Type
Chapter
Information
Researching the Autism Spectrum
Contemporary Perspectives
 , pp. 190 - 216
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Adolphs, R., Baron-Cohen, S., Tranel, D. (2002). Impaired recognition of social emotions following amygdala damage. Journal of Cognitive Neuroscience, 14: 1264–1274.CrossRefGoogle ScholarPubMed
Al-Ayadhi, L.Y. (2005). Altered oxytocin and vasopressin levels in autistic children in central Saudi Arabia. Neuroscience, 10: 47–50.Google ScholarPubMed
Allen, J.A., Halverson-Tamboli, R.A., Rasenick, M.M. (2007). Lipid raft microdomains and neurotransmitter signalling. Nature Reviews Neuroscience, 8: 128–140.CrossRefGoogle ScholarPubMed
Amaral, D.G., Schumann, C.M., Nordahl, C.W. (2008). Neuroanatomy of autism. Trends in Neurosciences, 31: 137–145.CrossRefGoogle ScholarPubMed
Anderson, G.M., Freedman, D.X., Cohen, D.J., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28: 885–900.CrossRefGoogle ScholarPubMed
Anderson, G.M., Gutknecht, L., Cohen, D.J.et al. (2002). Serotonin transporter promotor variants in autism: functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7: 831–836.CrossRefGoogle Scholar
Aneja, A., Tierney, E. (2008). Autism: The role of cholesterol in treatment. International Review of Psychiatry, 20: 165–170.CrossRefGoogle ScholarPubMed
Beaulieu, J.-M., Zhang, X., Rodriguiz, R.M., et al. (2008). Role of GSK3β in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences USA, 105: 1333–1339.CrossRefGoogle ScholarPubMed
Blaylock, R.L., Strunecka, A. (2009). Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Current Medicinal Chemistry, 16: 157–170.CrossRefGoogle ScholarPubMed
Brune, C.W., Kim, S.J., Salt, J., et al. (2006). 5-HTTLPR Genotype-specific phenotype in children and adolescents with autism. American Journal of Psychiatry, 163: 2148–2156.CrossRefGoogle ScholarPubMed
Campbell, M., Petti, T.A., Greene, W.H., et al. (1980). Some physical parameters of young autistic children. Journal of the American Academy of Child Psychiatry, 19: 193–212.CrossRefGoogle ScholarPubMed
Capone, G.T., Goyal, P., Grados, M., Smith, B., Kammann, H. (2008). Risperidone use in children with Down syndrome, severe intellectual disability and comorbid autistic spectrum disorders: a naturalistic study. Journal of Developmental and Behavioral Pediatrics, 29: 106–116.CrossRefGoogle ScholarPubMed
Carminati, G.G., Deriaz, N., Bertschy, G. (2006). Low-dose venlafaxine in three adolescents and young adults with autistic disorders improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms. Progress in Neuropsychopharmacology and Biological Psychiatry, 30: 312–315.CrossRefGoogle Scholar
Carter, C.S. (2007). Sex difference in oxytocin and vasopressin: implications for autism spectrum disorders? Behavioral Brain Research, 176: 170–186.CrossRefGoogle Scholar
Chavis, P., Westbrook, C. (2001). Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature, 411: 317–321.CrossRefGoogle Scholar
Cho, I.H., Yoo, H.J., Park, M., Lee, Y.S., Kim, S.A. (2007). Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Research, 1139: 34–41.Google ScholarPubMed
Chugani, D.C., Muzik, O., Rothermel, R., et al. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42: 666–669.CrossRefGoogle ScholarPubMed
Chugani, D.C., Muzik, O., Behen, M., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45: 287–295.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Conroy, J., Meally, E., Kearney, G., et al. (2004). Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Molecular Psychiatry, 9: 587–593.CrossRefGoogle Scholar
Cook, E.H., Leventhal, B.L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8: 348–354.CrossRefGoogle ScholarPubMed
CookJr., E.H., Courchesne, R., Lord, C., et al. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2: 247–250Google ScholarPubMed
Coskun, M., Mukaddes, N.M. (2008). Mirtazepine treatment in a subject with autistic disorder and fetishism. Journal of Child and Adolescent Psychopharmacology, 18: 206–209.CrossRefGoogle Scholar
Coutinho, A.M., Sousa, I., Martins, M., et al. (2007). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Human Genetics, 121: 243–256.CrossRefGoogle ScholarPubMed
Crawley, J.H., Chen, T., Puri, A., et al. (2007). Social approach behaviours in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides, 41: 145–163.CrossRefGoogle Scholar
Croonenberghs, J., Verkerk, R., Scharpe, S., Deboutte, D., Maes, M. (2005). Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences, 76: 2171–2183.CrossRefGoogle ScholarPubMed
Croonenberghs, J., Spass, K., Wauters, A., et al. (2008). Faulty serotonin-DHEA interactions in autism: results of the 5-hydroxytryptophan challenge test. Neuroendocrinology Letters, 29: 385–390.Google ScholarPubMed
Cross, S., Kim, S.J., Weiss, L.A., et al. (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology, 33: 353–360.CrossRefGoogle ScholarPubMed
Danfors, T., Knorring, A.L., Hartvig, P., et al. (2005). Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study. Journal of Clinical Psychopharmacology, 25: 485–489.CrossRefGoogle ScholarPubMed
D'Arcangelo, G. (2005). Apoer2: A Reelin receptor to remember. Neuron, 47: 471–473.CrossRefGoogle Scholar
Davis, E., Fennoy, I., Laraque, D., et al. (1992). Autism and developmental abnormalities in children with perinatal cocaine exposure. Journal of the National Medical Association, 84: 315–319.Google ScholarPubMed
Devlin, B., Bennett, P., Dawson, G., et al. (2004). Alleles of a Reelin CGG repeat do not convey liability to autism in a sample from the CPEA Network. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 126B: 46–50.CrossRefGoogle ScholarPubMed
Domes, G., Heinrichs, M., Michel, A., Berger, C., Herpertz, S.C. (2007). Oxytocin improves ‘mind-reading’ in humans. Biological Psychiatry, 61: 731–733.CrossRefGoogle ScholarPubMed
Dutta, S., Sinha, S., Ghosh, S., et al. (2008). Genetic analysis of reelin gene (RELN) SNPs: No association with autism spectrum disorder in the Indian population. Neuroscience Letters, 441: 56–60.CrossRefGoogle ScholarPubMed
Emamian, E.S., Hall, D, Birnbaum, M.F., et al. (2004). Convergent evidence for impaired AKT1-GSK3 beta signaling in schizophrenia. Nature Genetics, 36: 131–137.CrossRefGoogle Scholar
Falconer, D.S. (1951). Two new mutants, Trembler and ‘Reeler’ with neurological actions in the house mouse. Journal of Genetics, 50: 182–201.CrossRefGoogle ScholarPubMed
Fatemi, S.H. (2002). The role of Reelin in pathology of autism. Molecular Psychiatry, 7: 919–920.CrossRefGoogle ScholarPubMed
Fatemi, S.H., Realmuto, G.M., Khan, L., Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. Journal of Autism and Developmental Disorders, 28: 303–307.CrossRefGoogle ScholarPubMed
Fatemi, S.H., Kroll, J.L., Stary, J.M. (2001a). Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport, 12: 3209–3215.CrossRefGoogle ScholarPubMed
Fatemi, S.H., Stary, J.M., Halt, A.R., Realmuto, G.R. (2001b). Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. Journal of Autism and Developmental Disorders, 31: 529–535.CrossRefGoogle ScholarPubMed
Fatemi, S.H., Snow, A.V., Stary, J.M., et al. (2005). Reelin signaling is impaired in autism. Biological Psychiatry, 57: 777–787.CrossRefGoogle ScholarPubMed
Ferguson, J.N., Aldag, J.M., Insel, T.R., Young, L.J. (2001). Oxytocin in the medial amygdala is essential for social recognition in the mouse. Journal of Neuroscience, 21: 8278–8285CrossRefGoogle ScholarPubMed
Gale, S., Ozonoff, S., Lainhart, J. (2003). Brief report: pitocin induction in autistic and nonautistic individuals. Journal of Autism and Developmental Disorders, 33: 205–208.CrossRefGoogle ScholarPubMed
Gillberg, C., Billstedt, E. (2000). Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatrica Scandinavica, 102: 321–330.CrossRefGoogle ScholarPubMed
Gimpl, G., Wiegand, V., Burger, K., Fahrenolz, F. (2002). Cholesterol and steroid hormones: modulators of oxytocin receptor function. Progress in Brain Research, 139: 43–55.CrossRefGoogle ScholarPubMed
Goldberg, J., Anderson, G.H., Zwaigenbaum, L., et al. (2008). Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39: 97–104.CrossRefGoogle ScholarPubMed
Goldberg, W., Osann, K., Filipek, P., et al. (2003). Language and other regression: Assessment and timing. Journal of Autism and Developmental Disorders, 33: 607–616.CrossRefGoogle Scholar
Goldman, M., Marlow-O'Conner, M., Torres, I., Carter, C.S. (2008). Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophrenia Research, 98: 247–255.CrossRefGoogle ScholarPubMed
Green, L. A., Fein, D., Modahl, C., et al. (2001). Oxytocin and autistic disorder: alterations in peptide forms. Biological Psychiatry, 50: 609–613.CrossRefGoogle ScholarPubMed
Greenburg, B., Tolliver, T., Huang, S., et al. (1999). Genetic variation in the serotonin transporter promotor region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics, 88: 83–87.3.0.CO;2-0>CrossRefGoogle Scholar
Guhathakurta, S., Ghosh, S., Sinha, S., et al. (2006). Serotonin transporter promoter variants: Analysis in Indian autistic and control population. Brain Research, 1092: 28–35.CrossRefGoogle ScholarPubMed
Hellings, J.A., Kelley, L.A., Gabrielli, W.F., Kilgore, E., Shah, P. (1996). Sertraline response in adults with mental retardation and autistic disorder. Journal of Clinical Psychiatry, 57: 333–336.Google ScholarPubMed
Hollander, E., Cartwright, C., Wong, C., et al. (1998). A dimensional approach to the autism spectrum. CNS Spectrums, 3: 22–39.CrossRefGoogle Scholar
Hollander, E., Kaplan, A., Cartwright, C., Reichman, D. (2000). Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. Journal of Child Neurology, 15: 132–135.CrossRefGoogle Scholar
Hollander, E., Novotny, S., Hanratty, M., et al. (2003). Oxytocin infusion reduces repetitive behaviours in adults with autistic and Asperger's disorders. Neuropsychopharmacology, 28: 193–198.CrossRefGoogle ScholarPubMed
Hollander, E., Phillips, A., Chaplin, W., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30: 582–589.CrossRefGoogle ScholarPubMed
Hollander, E., Bartz, J., Chaplin, W., et al. (2007). Oxytocin increases retention of social cognition in autism. Biological Psychiatry, 61: 498–503.CrossRefGoogle ScholarPubMed
Howard, M.A., Cowel, P.E., Boucher, J., et al. (2000). Convergent neuroanatomical and behavioural evidence of an amygdala hypothesis of autism. Neuroreport, 11: 2931–2935.CrossRefGoogle ScholarPubMed
Hranilovic, D., Bujas-Petkovic, Z., Vragovic, R., et al. (2007). Hyperserotonemia in adults with autistic disorder. Journal of Autism and Developmental Disorders, 37: 1934–1940CrossRefGoogle ScholarPubMed
Hu, V.W., Nguyen, A., Kim, K.S., et al. (2009). Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One, 4: e5775.CrossRefGoogle ScholarPubMed
Jacob, S., Brune, C.W., Carter, C.S., et al. (2007). Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neuroscience Letters, 417: 6–9.CrossRefGoogle ScholarPubMed
Jansen, L.M.C., Gispen-de Wied, C.C., Wiegant, V.M., et al. (2006). Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. Journal of Autism and Developmental Disorders, 36: 891–899.CrossRefGoogle ScholarPubMed
Janusonis, S., Gluncic, V., Rakic, P. (2004). Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. Journal of Neuroscience, 24: 1652–1659.CrossRefGoogle ScholarPubMed
Jo, M., Fortune, J.E. (2002) Changes in oxytocin receptor in bovine preovulatory follicles between the gonadotropin surge and ovulation. Molecular and Cellular Endocrinology, 200: 31–43.CrossRefGoogle Scholar
Keltikangas-Järvinen, L., Salo, J. (2009). Dopamine and serotonin systems modify environmental effects on human behavior: a review. Scandinavian Journal of Psychology, 50: 574–582.CrossRefGoogle ScholarPubMed
Kirsch, P., Esslinger, C., Chen, Q., et al. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25: 11489–11493.CrossRefGoogle ScholarPubMed
Klauck, S.M., Poustka, F., Benner, A., Lesch, K.P., Poustka, A. (1997). Serotonin transporter (5-HTT) gene variants associated with autism? Human Molecular Genetics, 6: 2233–2238CrossRefGoogle ScholarPubMed
Kolevzon, A., Mathewson, K.A., Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. Journal of Clinical Psychiatry, 67: 407–414.CrossRefGoogle ScholarPubMed
Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U., Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435: 673–676.CrossRefGoogle ScholarPubMed
Kramer, K., Azmitia, E.C., Whitaker-Azmitia, P.M. (1994). In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Developmental Brain Research, 78: 142–146.CrossRefGoogle Scholar
Krebs, M.O., Betancur, C., Leroy, S., et al. (2002). Absence of association between a polymorphic GGC repeat in the 5' untranslated region of the reelin gene and autism. Molecular Psychiatry, 7: 801–804.CrossRefGoogle ScholarPubMed
Krueger, D.D., Howell, J.L., Hebert, B.F., et al. (2006). Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology, 189: 95–104.CrossRefGoogle ScholarPubMed
Leckman, J.F., Goodman, W.K., North, W.G., et al. (1994). Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Archives of General Psychiatry, 51: 782–792.CrossRefGoogle ScholarPubMed
Lerer, E., Levi, S., Salomon, S., et al. (2007). Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behaviour Scales and cognition. Molecular Psychiatry, 13: 980–988.CrossRefGoogle ScholarPubMed
Li, J., Nguyen, L., Gleason, C., et al. (2004). Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 126B: 51–57.CrossRefGoogle ScholarPubMed
Liu, W., Pappas, G.D., Carter, C.S. (2005). Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/–) reeler mice. Neurological Research, 27: 339–345.CrossRefGoogle ScholarPubMed
Magalhães-Nunes, A.P., Badauê-Passos, D. Jr., Rizo Ventura, R., et al. (2008). Sertraline, a selective serotonin reuptake inhibitor, affects thirst, salt appetite and plasma levels of oxytocin and vasopressin in rats. Experimental Physiology, 92: 913–922.CrossRefGoogle Scholar
Magdaleno, S., Keshvara, L., Curran, T. (2002). Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice. Neuron, 33: 573–586.CrossRefGoogle ScholarPubMed
Martin, A., Landau, J., Leebens, P., et al. (2000). Risperidone-associated weight gain in children and adolescents: a retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 10: 259–268.CrossRefGoogle ScholarPubMed
Martin, A., Koenig, K., Anderson, G.M., Scahill, L. (2003). Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. Journal of Autism and Developmental Disorders, 33: 77–85.CrossRefGoogle ScholarPubMed
Martin-Ruiz, C.M., Lee, M., Perry, R.H., et al. (2004). Molecular analysis of nicotinic receptor expression in autism. Molecular Brain Research, 123: 81–90.CrossRefGoogle ScholarPubMed
Mayes, S.D., Calhoun, S.L. (2003) Ability profiles in children with autism: Influence of age and IQ. Autism 7: 65–80.CrossRefGoogle ScholarPubMed
McBride, P.A., Anderson, G.M., Hertzig, M.E., et al. (1998). Effects of diagnosis, race and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37: 767–776.CrossRefGoogle ScholarPubMed
McDougle, C.J., Naylor, S.T., Cohen, D.J., et al. (1996a). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53: 993–1000.CrossRefGoogle ScholarPubMed
McDougle, C.J., Naylor, S.T., Cohen, D.J., et al. (1996b). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53: 1001–1008.CrossRefGoogle ScholarPubMed
McDougle, C.J., Scahill, L., McCracken, J.T., et al. (2000). Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child and Adolescent Psychiatric Clinics of North America, 9: 201–224.Google ScholarPubMed
McNamara, I.M., Borella, A.W., Bialowas, L.A., Whitaker-Azmitia, P.M. (2008). Further studies in the developmental hyperserotonemia model (DHS) in autism: Social, behavioral and peptide changes. Brain Research, 16: 203–214.CrossRefGoogle Scholar
Mitchell, B.F., Fang, X., Wong, S. (1998). Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition. Biology of Reproduction, 59: 1321–1327.CrossRefGoogle ScholarPubMed
Modahl, C., Green, L., Fein, D., et al. (1998). Plasma oxytocin levels in autistic children. Biological Psychiatry, 43: 270–277.CrossRefGoogle ScholarPubMed
Mukaetova-Ladinska, E.B., Arnold, H., Jaros, E., Perry, R., Perry, E. (2004). Laminar cytoarchitectonic changes and depletion of MAP2 expression in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathology and Applied Neurobiology, 30: 615–623.CrossRefGoogle ScholarPubMed
Mulder, E.J., Anderson, G.M., Kema, I.P., et al. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences within group distribution and behavioural correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43: 491–499.CrossRefGoogle Scholar
Murphy, D.G.M., Daly, E., Schmitz, N., et al. (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. American Journal of Psychiatry, 163: 934–936.CrossRefGoogle Scholar
Nagaraj, R., Singhi, P., Malhi, P. (2006). Risperidone in children with autism: randomized, placebo-controlled, double-blind study. Journal of Child Neurology, 21: 450–455.CrossRefGoogle ScholarPubMed
Nguyen, M., Murphy, T. (2001). Mirtazepine for excessive masturbation in an adolescent with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 40: 868–869.CrossRefGoogle Scholar
Oblak, A., Gibbs, T.T., Blatt, G.J. (2009). Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Research, 2: 205–219.CrossRefGoogle ScholarPubMed
Ogawa, M., Miyata, T., Nakajima, K., et al. (1995). The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron, 14: 899–912.CrossRefGoogle ScholarPubMed
Parikh, M.S., Kolevzon, A., Hollander, E. (2008). Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology, 18: 157–178.CrossRefGoogle ScholarPubMed
Pesold, C., Impagnatiello, F., Pisu, M.G., et al. (1998). Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proceedings of the National Academy of Sciences USA, 95: 3221–3226.CrossRefGoogle ScholarPubMed
Quattrocchi, C.C., Wannenes, F., Persico, A.M., et al. (2002). Reelin is a serine protease of the extracellular matrix. Journal of Biological Chemistry, 277: 303–309; erratum 277: 11616.CrossRefGoogle ScholarPubMed
Ragnauth, A.K., Devidze, N., Moy, V., et al. (2005). Female oxytocin gene-knockout mice, in a semi-natural environment, display exaggerated agressive behaviour. Genes Brain and Behavior, 4: 229–239.CrossRefGoogle Scholar
Ramoz, N., Reichert, J.G., Corwin, T.E., et al. (2006). Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biological Psychiatry, 60: 186–191.CrossRefGoogle ScholarPubMed
Roberts, R.C., Xu, L.Y., Roche, J.K., Kirkpatrick, B. (2005). Ultrastructural localization of reelin in the cortex in post-mortem human brain. Journal of Comparative Neurology, 482: 294–308.CrossRefGoogle ScholarPubMed
Rojas Wahl, R.U. (2004). Could oxytocin administration during labour contribute to autism and related behavioral disorders? – A look at the literature. Medical Hypothesis, 63: 456–460.CrossRefGoogle Scholar
Saher, G., Brugger, B., Lapper-Siefke, C., et al. (2005). High cholesterol level is essential for myelin membrane growth. Nature Neuroscience, 8: 468–475.CrossRefGoogle ScholarPubMed
Scott, L.J., Dhillon, S. (2007). Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Pediatric Drugs, 9: 343–354.CrossRefGoogle ScholarPubMed
Serajee, F.J., Zhong, H., Mahbubul Huq, A.H.M. (2006). Association of Reelin gene polymorphisms with autism. Genomics, 87: 75–83.CrossRefGoogle ScholarPubMed
Skaar, D.A., Shao, Y., Haines, J.L., et al. (2005). Analysis of the RELN gene as a genetic risk factor for autism. Molecular Psychiatry, 10: 563–571.CrossRefGoogle ScholarPubMed
Takahashi, S., Kanai, H., Miyamoto, Y. (1976). Reassessment of elevated serotonin levels in blood platelets in early infantile autism. Journal of Autism and Childhood Schizophrenia, 6: 317–326.CrossRefGoogle ScholarPubMed
Tom, N., Assinder, S.J. (2010). Oxytocin in health and disease. International Journal of Biochemistry and Cell Biology, 42: 202–205.CrossRefGoogle ScholarPubMed
Veenstra-VanderWeele, J., Anderson, G.M., Cook, E.H. Jr. (2000). Pharmacokinetics and the serotonin system: initial studies and future directions. European Journal of Pharmacology, 410: 165–181.CrossRefGoogle Scholar
Waage-Baudet, H., Lauder, J.M., Dehart, D.B., et al. (2003). Abnormal serotonergic development in a mouse model for Smith-Lemli-Opitz syndrome: Implications for autism. International Journal of Developmental Neuroscience, 21: 451–459.CrossRefGoogle Scholar
Weiss, L.A., Kosova, G., Delahanty, R.J., et al. (2006a). Variation in ITGB3 is associated with whole blood serotonin level and autism susceptibility. European Journal of Human Genetics, 14: 923–931.CrossRefGoogle ScholarPubMed
Weiss, L.A., Ober, C., CookJr, E.H. (2006b). ITGB3 shows genetic and expression interaction with SLC6A4. Human Genetics, 120: 93–100.CrossRefGoogle ScholarPubMed
West, L., Brunssen, S.H., Waldrop, J. (2009a). Review of the evidence for treatment with children of autism with selective reuptake serotonin inhibitors. Journal for Specialists in Pediatric Nursing, 14: 183–191.CrossRefGoogle Scholar
West, L., Waldrop, J., Brunssen, S.H. (2009b). Pharmacologic treatment for the core deficits and associated symptoms of autism in children. Journal of Pediatric Health Care, 23: 75–89.CrossRefGoogle ScholarPubMed
Winslow, J.T., Insel, T.R. (2002). The social deficits of the oxytocin knockout mouse. Neuropeptides, 36: 221–229.CrossRefGoogle ScholarPubMed
Wu, S., Jia, M., Ruan, Y., et al. (2005). Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biological Psychiatry, 58: 74–77.CrossRefGoogle ScholarPubMed
Yirmiya, N., Pilowsky, T., Nemanov, L., et al. (2001). Evidence for an association with the serotonin transporter promoter region polymorphism and autism. American Journal of Medical Genetics, 105: 381–386CrossRefGoogle ScholarPubMed
Ylisaukko-oja, T., Alarcón, M., Cantor, R.M., et al. (2005). Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families. Annals of Neurology, 59: 145–155.CrossRefGoogle Scholar
Zak, P.J., Stanton, A.A., Ahmadi, S. (2007). Oxytocin increases generosity in humans. PLoS ONE, 2: e1128.CrossRefGoogle ScholarPubMed
Zhang, H., Liu, X., Zhang, C., et al. (2002). Reelin gene alleles and susceptibility to autism spectrum disorders. Molecular Psychiatry, 7: 1012–1017.CrossRefGoogle ScholarPubMed
Zingg, H.H., Laporte, S.A. (2003) The oxytocin receptor. Trends in Endocrinology and Metabolism, 14: 222–227CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×